Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Ann Surg Oncol. 2022 Jul 27;29(12):7579–7588. doi: 10.1245/s10434-022-12085-z

Figure 3.

Figure 3

Figure 3

A: Classification and regression tree analysis of patients with completely resected colorectal liver metastases and hepatic artery infusion chemotherapy demonstrating three terminal nodes of genomic risk for recurrence (n=172); PE: parameter estimate; B: Stratification of recurrence-free survival by the three genomic risk groups; alt-RAS-alt-TP53, alt-RAS-wt-TP53, wt-RAS. Number at risk over time indicated in the adjoining risk table.